Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

(2022) Steven H.J. Hageman et al.   EUROPEAN HEART JOURNAL

Low density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study

(2022) Kausik K Ray et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

(2021) Maurizio Averna et al.   ATHEROSCLEROSIS

TRS2P and LDL-C alone or in combination for predicting absolute benefits from additional LDL-C lowering: Analysis from the TNT trial

(2021) Toshiyuki Nishikido et al.   ATHEROSCLEROSIS

Lipid management across Europe in the real-world setting: a rapid evidence review

(2021) Vivencio Barrios et al.   CURRENT MEDICAL RESEARCH AND OPINION

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

(2021) Frank L J Visseren et al.   EUROPEAN HEART JOURNAL

Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals

(2021) Ailsa J McKay et al.   European Journal of Preventive Cardiology

Combination lipid-lowering therapy as first-line strategy in very high-risk patients

(2021) Kausik K Ray et al.   EUROPEAN HEART JOURNAL

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia

(2020) Maciej Banach et al.   JAMA Cardiology

DA VINCI study: Change in approach to cholesterol management will be needed to reduce the implementation gap between guidelines and clinical practice in Europe

(2020) Jane K. Stock   ATHEROSCLEROSIS

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

(2019) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

(2019) Kausik K. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease

(2019) Christopher P. Cannon et al.   AMERICAN HEART JOURNAL

Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe

(2018) Jean Ferrieres et al.   European Journal of Preventive Cardiology

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients

(2016) Anselm K. Gitt et al.   ATHEROSCLEROSIS

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective

(2016) Lotte Kaasenbrood et al.   CIRCULATION

Cardiovascular disease in Europe: epidemiological update 2016

(2016) Nick Townsend et al.   EUROPEAN HEART JOURNAL

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

(2016) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION